Eikelberg, D.; Lehmbecker, A.; Brogden, G.; Tongtako, W.; Hahn, K.; Habierski, A.; Hennermann, J.B.; Naim, H.Y.; Felmy, F.; Baumgärtner, W.;
et al. Axonopathy and Reduction of Membrane Resistance: Key Features in a New Murine Model of Human GM1-Gangliosidosis. J. Clin. Med. 2020, 9, 1004.
https://doi.org/10.3390/jcm9041004
AMA Style
Eikelberg D, Lehmbecker A, Brogden G, Tongtako W, Hahn K, Habierski A, Hennermann JB, Naim HY, Felmy F, Baumgärtner W,
et al. Axonopathy and Reduction of Membrane Resistance: Key Features in a New Murine Model of Human GM1-Gangliosidosis. Journal of Clinical Medicine. 2020; 9(4):1004.
https://doi.org/10.3390/jcm9041004
Chicago/Turabian Style
Eikelberg, Deborah, Annika Lehmbecker, Graham Brogden, Witchaya Tongtako, Kerstin Hahn, Andre Habierski, Julia B. Hennermann, Hassan Y. Naim, Felix Felmy, Wolfgang Baumgärtner,
and et al. 2020. "Axonopathy and Reduction of Membrane Resistance: Key Features in a New Murine Model of Human GM1-Gangliosidosis" Journal of Clinical Medicine 9, no. 4: 1004.
https://doi.org/10.3390/jcm9041004
APA Style
Eikelberg, D., Lehmbecker, A., Brogden, G., Tongtako, W., Hahn, K., Habierski, A., Hennermann, J. B., Naim, H. Y., Felmy, F., Baumgärtner, W., & Gerhauser, I.
(2020). Axonopathy and Reduction of Membrane Resistance: Key Features in a New Murine Model of Human GM1-Gangliosidosis. Journal of Clinical Medicine, 9(4), 1004.
https://doi.org/10.3390/jcm9041004